γH2AX焦点检测揭示头颈部鳞癌模型瘤内异质性
本研究分析3种头颈部鳞癌肿瘤模型离体照射后γH2AX焦点的瘤内异质性,以评估其预测放射敏感性的潜力。再氧合时间对焦点计数无显著影响,但同一肿瘤不同标本及同一标本不同视野间存在显著瘤内异质性,提示临床需多标本分析和自动化焦点分析。
要点
- 离体再氧合10h与24h对γH2AX焦点计数无显著影响,支持该检测在临床环境中的适用性。
- 所有肿瘤模型均显示同一肿瘤不同标本间及同一标本不同显微镜视野间存在显著瘤内异质性。
- 瘤内高异质性提示每位患者需多个可分析样本,因而需要自动化焦点分析。
核心结论
- 离体再氧合10h与24h的γH2AX焦点结果相似,支持该检测在临床环境中的适用性。
- 瘤内高异质性表明需要每位患者多个可分析样本,因而需要自动化焦点分析。
研究设计与样本
- 在3种已知放射敏感性差异的头颈部鳞癌肿瘤模型中量化离体照射后的γH2AX焦点。
- 肿瘤标本经培养基再氧合(10h、24h)、单剂量照射(0Gy、4Gy)及照射后24h固定后分析。
- 对同一肿瘤多个同等处理样本分析焦点,归一化后拟合线性混合效应模型。
主要发现
- 离体再氧合时间对γH2AX焦点计数无显著影响。
- FaDu模型显示显著的模型内异质性(p=0.033)。
- SKX(p=0.167)和UT-SCC-5(p=0.082)模型未显示显著的模型内异质性。
- 所有肿瘤模型均显示同一肿瘤不同标本间(p<0.01)或同一标本不同显微镜视野间(p<0.0001)的显著瘤内异质性。
临床怎么用
- γH2AX焦点检测可在离体再氧合10h至24h的时间窗内应用于临床样本分析。
- 临床应用中需对每位患者采集多个可分析样本以应对瘤内异质性。
- 建议采用自动化焦点分析以满足多标本分析的需求。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aimed to analyze the intra-tumoral heterogeneity of γH2AX foci in tumor specimens following ex vivo radiation to evaluate the potential of γH2AX foci as predictors for radiosensitivity. MATERIAL AND METHODS: γH2AX foci were quantified in tumor specimens of 3hHNSCC tumor models with known differences in radiosensitivity after reoxygenation in culture medium (10h, 24h), single dose exposure (0Gy, 4Gy), and fixation 24h post-irradiation. Multiple, equally treated samples of the same tumor were analyzed for foci, normalized and fitted in a linear mixed-effects model. RESULTS: The ex vivo reoxygenation time had no significant effect on γH2AX foci counts. A significant intra model heterogeneity could be shown for FaDu (p=0.033) but not for SKX (p=0.167) and UT-SCC-5 (p=0.082) tumors, respectively. All tumor models showed a significant intra-tumoral heterogeneity between specimens of the same tumor (p<0.01) or among microscopic fields of a particular tumor specimen (p<0.0001). CONCLUSION: Similar results for ex vivo γH2AX foci between 10h and 24h reoxygenation time support the applicability of the assay in a clinical setting. The high intra-tumoral heterogeneity underlines the necessity of multiple analyzable samples per patient and therewith the need for an automated foci analysis.
引用
- Rassamegevanon T, Löck S, Range U, et al. Tumor heterogeneity determined with a γH2AX foci assay: A study in human head and neck squamous cell carcinoma (hHNSCC) models. Radiother Oncol. 2017. PMID: 28739384. doi:10.1016/j.radonc.2017.06.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。